key: cord-0888666-xzmofilh
authors: Szabó, Lara U.; Kaiser, Marcel; Mäser, Pascal; Schmidt, Thomas J.
title: Antiprotozoal Nor-Triterpene Alkaloids from Buxus sempervirens L.
date: 2021-06-10
journal: Antibiotics (Basel)
DOI: 10.3390/antibiotics10060696
sha: 6c046650ccb27136d07f47f151544f4af0ed2eaa
doc_id: 888666
cord_uid: xzmofilh

Malaria and human African trypanosomiasis (HAT; sleeping sickness) are life-threatening tropical diseases caused by protozoan parasites. Due to limited therapeutic options, there is a compelling need for new antiprotozoal agents. In a previous study, O-tigloylcyclovirobuxeine-B was recovered from a B. sempervirens L. (common box; Buxaceae) leaf extract by bioactivity-guided isolation. This nor-cycloartane alkaloid was identified as possessing strong and selective in vitro activity against the causative agent of malaria tropica, Plasmodium falciparum (Pf). The purpose of this study is the isolation of additional alkaloids from B. sempervirens L. to search for further related compounds with strong antiprotozoal activity. In conclusion, 25 alkaloids were obtained from B. sempervirens L., including eight new natural products and one compound first described for this plant. The structure elucidation was accomplished by UHPLC/+ESI-QqTOF-MS/MS and NMR spectroscopy. The isolated alkaloids were tested against Pf and Trypanosoma brucei rhodesiense (Tbr), the causative agent of East African sleeping sickness. To assess their selectivity, cytotoxicity against mammalian cells (L6 cell line) was tested as well. Several of the compounds displayed promising in vitro activity against the pathogens in a sub-micromolar range with concurrent high selectivity indices (SI). Consequently, various alkaloids from B. sempervirens L. have the potential to serve as a novel antiprotozoal lead structure.

Buxus sempervirens L. (common box; Buxaceae) is an evergreen shrub or small tree, with nor-triterpene alkaloids of the nor-cycloartane type as its main chemical constituents. Decoctions of leaves were ethnopharmacologically used against a variety of indications, including malaria [1, 2] .

Malaria is a life-threatening infectious disease caused by protozoans of the genus Plasmodium. The vector of these parasites is the infected female Anopheles mosquito. The World Health Organization (WHO) estimated that 229 million malaria cases and 409,000 malaria deaths occurred worldwide in 2019. The incidence has remained virtually unchanged in recent years and, because of the coronavirus pandemic, the WHO estimated 100,000 additional deaths in 2020. The progress in the fight against malaria has stalled. There is a high incidence of treatment failure due to resistance and, thus, the development of new antimalarial drugs is indispensable.

Phytochemical studies on B. sempervirens L. led to the isolation of almost 200 alkaloids [3] , which have displayed interesting bioactivities including antibacterial, antimycobacterial, antimalarial, and acetyl-and butyryl-cholinesterase inhibition activity [4, 5] .

In a previous study by our group [6] , O-tigloylcyclovirobuxeine-B, after bioactivityguided isolation from the dichloromethane extract of B. sempervirens leaves, was identified as the constituent mainly responsible for the plant's antiplasmodial activity. It appeared likely that further congeneric alkaloids also yield contributions to the overall antiplasmodial effect of the total leaf extract. Moreover, a lupane triterpene of B. sempervirens L. showed prominent bioactivity even against drug-resistant malaria parasites [7] . Consequently, the isolation, as well as the antiplasmodial testing of further Buxus-alkaloids, is of great interest.

In a recent study [8] , it was determined that the alkaloid-enriched fraction of Pachysandra terminalis (Buxaceae) possessed promising activity against another protozoan parasite, Trypanosoma brucei rhodesiense (Tbr), the causative agent of East African sleeping sickness, a poverty-related neglected tropical disease. This plant contains aminosteroids structurally related to the nor-triterpene alkaloids of B. sempervirens L. Furthermore, an isolated compound of B. sempervirens L., cyclovirobuxeine-B, was found to be highly active and selective against Tbr in vitro [9] . These findings suggested that additional Buxus-alkaloids could likewise represent strong trypanocides. The chemotherapeutic agents currently in use against African sleeping sickness (human African trypanosomiasis (HAT)) are toxic and have many other associated disadvantages, such as long hospitalization. Accordingly, there is a compelling need for new treatments.

The aim of this study was the identification and characterization of potent and selective antiprotozoal compounds as lead structures against tropical diseases. For this purpose, we report on the systematic isolation of 25 alkaloids from a B. sempervirens L. leaf extract, including eight new natural products and one compound first described for this plant. The compounds were obtained by centrifugal partition chromatography (CPC), preparative high performance liquid chromatography (prep-HPLC), and column chromatography (CC). Additionally, we present the results of the in vitro testing of the isolated alkaloids against the pathogens of malaria and HAT.

The isolation scheme of alkaloids from B. sempervirens L. (Scheme 1) consisted of various separation methods such as CPC, prep-HPLC, and CC. It resulted in the isolation of 25 compounds. The structure elucidation and identification of the isolated Buxus-alkaloids were accomplished by UHPLC/+ESI-QqTOF-MS/MS (henceforth termed "LC/MS") and NMR spectroscopy. Eighteen alkaloids (1-18), with a 9β-19-cyclo-5α-pregnane core skeleton, were isolated in addition to one steroidal alkaloid (19) and six substances, which possess a (9(10→19))abeo-5α-pregnane core skeleton (20) (21) (22) (23) (24) (25) (Figure 1 ). The spectral data of the previously known compounds (Table 1) , O-tigloylcyclovirobuxeine-B (1) [6, 10, 11] , cyclovirobuxeine-B (2) [9, 12] , cyclomicrophylline-A (5) [13, 14] , cyclomicrophyllidine-A (6) [15, 16] , N-benzoyl-O-acetyl-cycloxo-buxoline-F (9) [10] , N-benzoyl-cycloxo-buxoline-F (10) [10] , N b -dimethylcycloxobuxoviricine (12) [17] , (E)-cyclobuxophyllinine-M (13) and (Z)-cyclobuxophyllinine-M (14) [18, 19] , (E)-cyclosuffrobuxinine-M (15) and (Z)-cyclosuffro buxinine-M (16) [20] [21] [22] , cyclomicrobuxinine (17) [21, 23] , cyclomicrobuxine (18) [23] , irehine (19) [24], 16-α-hydroxybuxaminone (20) [25] , N 20 -acetylbuxamine-E (21) [26] , and N-benzoyl-O-acetylbuxodienine-E (22) [27] , were in full agreement with findings reported in the literature. Additionally, 2D-NMR spectra (COSY, HSQC, and HMBC) were evaluated to confirm the identification of the known compounds. To the best of our knowledge, cyclomicrophyllidine-A (6), previously known only from B. microphylla Sieb. et Zucc., has been isolated from the leaves of B. sempervirens L. for the first time. (Table 2 ; Figures S54-S62, Supplementary Materials) for the major part were in agreement with the previous 9β-19-cyclo-5α-pregnane derivatives (1-7). In the 1 H-NMR spectrum the two doublet signals (J = 4.6 Hz) of the methylene group at C-19 of the cyclopropane ring could be detected at δH = 0.80 and 0.71. This downfield shift in comparison to the corresponding signal in compounds 1-7, which all display the signal for one of the protons at C-19 between δH = 0.4 and −0.2, indicates the absence of anisotropic shielding by the Δ 6 double bond. This observation was in full agreement with the absence of an olefinic proton signal for position 6 and so, in conclusion, the B-ring in 8 is fully saturated [17, 28] . In addition, the typical proton signals of a benzoic acid ester at δH = 8.06 The carbonyl carbon of the ester resonated at δ C = 166.74 and showed 3 J couplings in the 1 H/ 13 C-HMBC spectrum with the protons in position 2 of the A-ring and positions 2 /6 of the benzoic acid. The proton in position 2, accordingly, displayed the usual chemical shift caused by geminal relationship with an ester group, i.e., δ H = 5.30 (td (1H), J = 10.9 and 4.8 Hz) [29] . The signals at δ H = 2.96 (s (3H)) and 2.67 (s (3H)) indicated a Buxusalkaloid with two monomethylated amino groups at C-3 and C-20. The resulting structure is presented in Figure 2 .

For compound 11, the molecular formula was determined as C 26 H 43 NO 3 by LC/MS ( Figures S71-S73 , Supplementary Materials). In the 1 H, 13 C, and HSQC-NMR spectra for 11 ( Table 2; In the 13 C-NMR spectrum, a signal at δc = 217.33 could be detected in the low field in the typical shift range of a ketone [29] . The 2 J and 3 J couplings in the 1 H/ 13 C-HMBC spectrum of the ketone carbon with positions 1, 2, 29 and 30 clearly assigned it to C-3. This position also appears plausible from a biosynthetic point of view [28] for the elucidated new structure ( Figure 2 ).

In the +ESI-QqTOF MS/MS spectrum ( Figure S121 , Supplementary Materials), compound 23 exhibited identical fragmentation (the fragmentation pathway is reported for the first time in Figure S122 Figure S114 , Supplementary Materials), was not detectable. The signals of the NMR spectra (Table 3 ; Figures S124-S133, Supplementary Materials) of 22 and 23 were very similar for the most part. Deviations occurred in the chemical shifts at positions C-11 and C-19 in the A-ring. In the 1 H/ 13 C-HSQC spectrum of compound 23, two signals could be detected at δ H = 5.42 (br s)/δc = 121.95, as well as δ H = 5.31 (br m)/δc = 119.37, which indicated olefinic structural elements. In the 1 H/ 13 C-HMBC spectrum, these signals did not show any interaction with each other, as would be expected in a conjugated ∆ 9(11),10(19) system as found in 22. Instead, the chemical shifts agree with a (9-(10→19))abeo-pregnane with the presence of two isolated double bonds, i.e., ∆ 1(10) and ∆ 9 (11) [28, 30] . Consequently, compound 23 could be identified as a constitutional isomer of 22 with a double bond between C-1 and C-10, instead of C-10 and C-19 ( Figure 2 ). (Table 3; Figures S137-S145, Supplementary Materials), compound 24, in analogy with 23, could clearly be assigned to the Buxus-alkaloids with a (9-(10→19))abeo-pregnane backbone and isolated double bonds between C-1 and 10 and between C-9 and 11. The acetamide group, already suspected by the fragmentation, could be located at the nitrogen atom at C-20 by the cross signal of the carbonyl carbon (δ C = 170.18) with the proton at position 20 (δ H = 3.99) in the 1 H/ 13 C-HMBC spectrum. This amide group has a significantly reduced basicity in contrast to the secondary amine group in position 3, which provides an explanation for the low intensity of the [M + 2H] 2+ quasimolecular ion in the +ESI-QqTOF mass spectrum. The resulting structure is presented in Figure 2 .

The (Table 3 ; Figures S149-S158, Supplementary Materials), compound 25 was clearly identified as a Buxus-alkaloid with a (9-(10→9))abeopregnane skeleton and isolated double bonds between C-1 and C-10 and between C-9 and C-11. A methine proton signal at δ H = 3.84 (δ C = 73.7 according to the 1 H/ 13 C-HSQC spectrum) resonated as a quartet (J = 6.1 Hz) and should therefore be in geminal position with a methyl group and must represent position 20. In the 1 H/ 13 C-HMBC spectrum, this proton showed cross peaks with carbons at δ C = 18. 

After isolation, all alkaloids were tested in vitro for antiplasmodial and antitrypanosomal activity against Plasmodium falciparum (Pf) and Trypanosoma brucei rhodesiense (Tbr). Furthermore, to assess their selectivity against the parasites, cytotoxicity against L6 rat skeletal myoblasts, as mammalian control cells, was tested (Table 4 ). All IC 50 values are expressed in µg/mL and values in µM are given in parentheses. While * n = 3 was reported as the mean value from three independent measurements with the standard deviation, all other values were determined with n = 2 as the mean value from two independent measurements with the fluctuation range. Note that the purity of compound 10 was <90%, so that activity was not determined. 1, 2, 5, 9, 11-16 ) and the steroidal alkaloid (19) displayed moderate activities with IC 50 values in the range of 1.05 to 4.3 µM. The (9-(10→19))abeo-5α-pregnanes (20) (21) (22) (23) (24) (25) were less active with IC 50 values of >4.0 µM.

Promising antitrypanosomal activities with IC 50 values between 1.1 and 1.5 µM were recorded for compounds 2, 6, 8 and 24. In common with the tests against Pf, O-benzoylcycloprotobuxoline-D (8) (IC 50 1.1 µM; SI 12) was the most effective antitrypanosomal Buxus-alkaloid in this set of compounds. Cyclomicrophylline-A (5) showed the highest selectivity against Tbr (SI 42) . Compounds 1, 4, 5, 7, 9 and 13-16 were moderately active, with IC 50 values varying between 2.1 and 3.6 µM. The IC 50 values of the other alkaloids against Tbr were >5.7 µM, indicating a low level of activity.

The same plant material was used as described previously [11] .

The extraction of plant material, the first part of the isolation procedure, and the isolation of O-tigloylcyclovirobuxeine-B (1) was equal to our previous study (Scheme 1) [11] .

After the second CPC separation of Fraction 2 (F2) [11] , test tubes 44-47 (7 mg) contained compound 4 as a main constituent. A Sephadex-LH 20 column (15 × 40 cm, flow 0.4 mL/min) was applied for purification of 4 using MeOH (isocratic, 100 mL) as eluent. Compound 4 (2.2 mg) was obtained as a white powder. The CPC test tubes 55-60 consisted of pure compound 6 (11.8 mg). CPC fractions 5 + 6 (103. CPC fractions F14 and F18+F19 presented 18 (28.6 mg) and 17 (391.5 mg) as pure compounds, respectively. Compound 23 (10.0 mg) was obtained from the crude dichloromethane extract by CC on silica gel (Merck, type-60, 70-230 mesh). The separation was introduced by gradient elution of ethyl acetate (EtOAc) (100%) until eluates became clear (eluates contained no alkaloid), followed by EtOAc saturated with aq. ammonia (3.5 L, flow 1 mL/min). Six fractions (five alkaloidal) were collected in 20 mL tubes (Bs1, Bs2a, Bs3a, Bs4a, Bs5a (starting from tube 78) and Bs6a). Bs2a was further purified using isocratic aq. ammoniasaturated EtOAc in a smaller silica gel column (flow 0.4 mL/min) and yielded 10.0 mg of compound 23 (white powder).

The corresponding free alcohols 2 and 5 were obtained from the already isolated compounds 1 and 6 by non-aqueous alkaline ester hydrolysis [34, 35] . The esters 1 (32.0 mg) and 6 (4.7 mg) were hydrolyzed with 0.5 N NaOH in a dichloromethane-methanol mixture (9: 1 v/v) at room temperature. The completion of the reaction (1 to 2: 4 1 2 h and 6 to 5: 6 d, 14 1 2 h) was monitored by thin layer chromatography (TLC plate silica gel 60 F 254 , Merck KGaA, Darmstadt, Germany; mobile phase: butan-1-ol:H 2 O:CH 3 COOH (10:3:1) (v/v/v), detected with Liebermann-Burchard reagent (acetic anhydride (5 mL), sulfuric acid (5 mL), and ethanol (50 mL), European Pharmacopoeia Reagent)), and the resulting alcohols were purified by extraction (four times with 100 mL dichloromethane). The yield in each case was >85%: 2 (22.8 mg) and 5 (3.2 mg). Since these two compounds are only found in small amounts in the crude extract of B. sempervirens L., ester hydrolysis was used to increase the yield.

NMR spectra were recorded on an Agilent DD2 600 MHz spectrometer (Agilent, Santa Clara, CA, USA) at 25 • C in CDCl 3 or CD 3 OD. Spectra were referenced to the solvent signals (CDCl 3 : 1 H: 7.260 ppm; 13 C: 77.160 ppm; CD 3 OD: 1 H: 3.310 ppm; and 13 C: 49.000 ppm) and were evaluated with MestReNova version 11.0 software (Mestrelab Research, Santiago de Compostela, Spain).

UHPLC/+ESI-QqTOF-MS/MS measurements were performed as described previously [11] . The sample concentration of the crude extract was 10 mg/mL in case of the CPC fractions 1 mg/mL, and for the isolated compounds it was 0.1 mg/mL. UV spectra of compounds 22 and 23 were recorded with a U-2900 spectrophotometer (Hitachi, Tokyo, Japan) in methanol.

O-tigloylcyclovirobuxeine-B (1): previously described in [6, 11] 1H, m, H-6α), 1.66 (1H, m, H-15β), 1.64 (1H, m, H-16β), 1.62 (1H, m, H-7α 29-hydroxy-cyclomikuranine-L (11): colorless gum; 1 H NMR and 13 C NMR (600/150 MHz, CD 3 OD) see Table 3 ;

+ESI 

CDCl 3 ; δ (ppm), intensity, mult

1.72 (1H, m, H-12β (Z)), 1.60 (1H, m, H-2β), 1.57 (1H, m, H-6α), 1.51 (1H, m, H-1β), 1.42 (1H, m, H-7α), 1.37 (1H, m, H-11β)

C-29 (E)), 62.83 (CH, C-3 (Z)), 62.81 (CH, C-3 (E)), 50.76 (CH 2 , C-15 (Z)), 49.30 (CH 2 , C-15 (E)), 46.84 (qC, C-13 (E))

2.19 (1H, m, H-11α), 2.17 (1H, m, H-2α), 2.15 (3H, s, H-21), 2.10 (1H, m, H-5), 2.02 (1H, m, H-12α), 1.94 (1H, m, H-15α), 1.76 (1H, m, H-1α), 1.71 (1H, m, H-12β)

65 (CH, C-3), 48.51 (qC, C-14), 47.77 (qC, C-13), 47.28 (CH, C-8)

49 (6H, br s, H-31/32), 2.19 (1H, m, H-11α), 2.16 (3H, s, H-21

64 (CH, C-3), 48.49 (qC, C-14), 47.76 (qC, C-13)

87 (3H, s, H-33/34), 2.70 (3H, s, H-33/34), 2.24 (1H, m, H-4α), 2.21 (1H, m, H-4β)

67.01 (CH, C-20), 57.58 (CH, C-14), 53.13 (CH, C-17)

16-α-hydroxybuxaminone (20): light yellow powder; 1 H NMR (600 MHz

99 (1H, d, 6.6, H-17), 2.94 (3H, s, H-31/32), 2.79 (3H, s, H-31/32), 2.52 (1H, d

34 (CH, C-3), 71.76 (CH, C-16), 69.03 (CH, C-17), 51.77 (CH, C-5), 48.94 (CH, C-8), 48.15 (qC, C-14)

97 (3H, s, H-31/32), 2.79 (3H, s, H-31/32), 2.41 (1H, m, H-1α)

26 (CH, C-17), 52.04 (CH, C-5), 50.73 (CH, C-8), 49.84 (qC, C-14), 49.55 (CH, C-20)

37 (1H, m, H-17), 2.35 (1H, m, H-12α), 2.30 (6H, s, H-31/32), 2.30 (1H, m, H-1α)

46 (CH, C-3 /5 ), 129.13 (CH, C-11), 128.28 (CH, C-2 /6 ), 80.75 (CH, C-16)

CD 3 OD) see Table 3

20-dihydroxybuxadine-M (25): colorless gum; 1 H NMR and 13 C NMR (600/150 MHz

Leishmania donovani (Ldo) (amastigotes, MHOM-ET-67/L82 strain) and Pf (intraerythrocytic forms, NF54 strain), and cytotoxicity tests against mammalian cells (L6-cell line from rat-skeletal myoblasts), were performed at the Swiss Tropical and Public Health Institute

The alkaloids were inactive against Tc and Ldo at the concentration tested. Such a pattern of activity was also observed in other studies

The structure of eight new natural products could be elucidated and the NMR data of already known Buxus-alkaloids are reported here in full for the first time. Moreover, cyclomicrophyllidine-A (6) was primarily obtained from the leaves of B. sempervirens L. Several of the isolated compounds displayed promising and selective in vitro activity against the protozoan parasites Pf and Tbr. Of the 25 structures isolated, five compounds (3, 4, 6-8) showed auspicious antiplasmodial activity with IC 50 values of <1.0 µM. Against the causative agent of HAT, compound 2, 6, 8, and 24 exhibited interesting IC 50 values in the range of 1.1-1.5 µM. The new natural product O-benzoylcycloprotobuxoline-D (8) was the most active substance in both cases. The highest selectivity was reached by cyclomicrophyllidine-B (7) (SI 145 for Pf ) and cyclomicrophylline-A (5) (SI 42 for Tbr), respectively. Accordingly, these Buxus-alkaloids have the potential to serve References 1. Neves

Phytotherapy in the Valnerina Marche (Central Italy)

Diterpenoid and steroidal alkaloids

Buxus Steroidal Alkaloids: Chemistry and Biology; The Alkaloids: Chemistry and Biology

Antiprotozoal activity of Buxus sempervirens and activity-guided isolation of O-tigloylcyclovirobuxeine-B as the main constituent active against Plasmodium falciparum

Identification of Compounds with Efficacy against Malaria Parasites from Common North American Plants

The Alkaloid-Enriched Fraction of Pachysandra terminalis (Buxaceae) Shows Prominent Activity against Trypanosoma brucei rhodesiense

A 3D-QSAR Study on the Antitrypanosomal and Cytotoxic Activities of Steroid Alkaloids by Comparative Molecular Field Analysis

Buxus alkaloids-XII

Target-Guided Isolation of O-tigloylcyclovirobuxeine -B from Buxus sempervirens L. by Centrifugal Partition Chromatography

Buxus Alkaloids. X. 1 The Isolation and Constitution of Cyclovirobuxeine-B

Buxus alkaloids. Part, I. The structures of three new alkaloids

Chemical Constituents of Buxus sempervirens

Isolation and structure elucidation of eight new alkaloids

Composition of alkaloids in different box tree varieties and their uptake by the box tree moth Cydalima perspectalis

New cholinesterase-inhibiting triterpenoid alkaloids from Buxus hyrcana

Buxarin und Buxenon, zwei neue Alkaloide aus Buxus sempervirens L. Die Pharm

Chemical Constituents of Buxus sempervirens

Buxus alkaloids. Part VII. The isolation and the constitutions of ten new alkaloids from the weak-base fractions of two species, B. microphylla Sieb. et Zucc. var. suffruticosa Makino and B. microphylla Sieb. et Zucc. var. suffruticosa Makino forma major Makino

Alkaloids from the Leaves of Buxus sempervirens

New steroidal alkaloids from Buxus longifolia

Alkaloids from Buxus sempervirens L. V. Configuration of buxtauine and buxpiine

Alkaloids from Buxus sempervirens var. argentea Hort. ex

Alkaloids from Buxus species

Four steroidal alkaloids from the leaves of Buxus sempervirens

Alkaloide aus Buxus sempervirens L

Terpenoid alkaloids of the Buxaceae family with potential biological importance

New Triterpenoidal Alkaloids from Buxus hyrcana

Chapter 8 Steroid Alkaloids: Alkaloids of Apocynaceae and Buxaceae; The Alkaloids: Chemistry and Physiology

Hagers Enzyklopädie der Arzneistoffe und Drogen

Structurally diverse alkaloids from Buxus sempervirens with cardioprotective activity

A simple method for the alkaline hydrolysis of esters

Steroid Alkaloids from Holarrhena africana with Strong Activity against Trypanosoma brucei rhodesiense

Structure-Activity Relationships of Cinnamate Ester Analogues as Potent Antiprotozoal Agents

Mining Sudanese Medicinal Plants for Antiprotozoal Agents

The authors declare no conflict of interest.

Antibiotics 2021, 10, 696 20 of 21 as antiprotozoal lead structures. Structure-activity relationship studies are in progress in order to identify structural functionalities that increase activity and reduce toxicity. In conclusion, the work presented here may represent an important first step in the development of this new class of antiprotozoal drugs against malaria and HAT.Supplementary Materials: The following are available online at https://www.mdpi.com/article/ 10.3390/antibiotics10060696/s1, the 1 H and 13 C NMR spectra of all the isolated compounds are provided as Supplementary Figures S1-S4 , S8-S11, S21-S24, S31-S38, S42-S45, S54-S57, S63-S70, S74-S77, S82-S118, S124-S127, S137-S140, and S149-S152. For the new natural products, additional LC/MS chromatograms, UV, and 2D NMR spectra, as well as key correlations of HMBC and COSY spectra, are supplied as Supplementary Figures S5-S7 , S12-S20, S25-S30, S39-S41, S46-S53, S58-S62, S71-S73, S78-S81, S119-S123, S128-S136, S141-S148, and S153-158.